© 2026 Sinochem Nanjing Corporation,
All Right Reserved
Chlorquinaldol, a halogenated hydroxyquinoline, first came into the medical scene in the early 20th century. Researchers searching for better antimicrobial tools against skin and mucosal infections found promise in hydroxyquinolines. They introduced a chlorine atom to the molecule, hoping for stronger activity and broader coverage. The journey of chlorquinaldol into clinical settings highlights the drive for practical, cost-effective solutions during eras of rampant infectious diseases, particularly before the widespread use of antibiotics. Hospitals and physicians depended on products that handled both bacteria and some fungi, especially those causing ringworm and oral infections. As someone who has worked in pharmaceutical history archiving, the archival notes tell stories of doctors in the 1930s mixing simple ointments containing chlorquinaldol, hoping for relief where older therapies failed or proved too harsh. Chlorquinaldol’s era tells us about the persistence to find new weapons when old ones start falling short.
Usually available as a yellowish powder or formulated in creams, ointments, and lozenges, chlorquinaldol occupies a niche among topical and mucosal antiseptics. It is best known for its use in skin preparations and oral hygiene products in Europe and South America, though it sees less frequent application in North America. I have seen its name crop up on labels for throat lozenges, showcasing its goal to tackle superficial infections without too much local irritation. It brings broad-spectrum activity to the table: useful for skin, mouth, and sometimes gynecological applications. While antibiotic resistance garners headlines, people sometimes overlook non-antibiotic antiseptics like chlorquinaldol that quietly provide alternatives in wound care and hygiene.
Chlorquinaldol presents as a pale to bright yellow crystalline powder, nearly odorless. Its melting point hovers around 145–149°C. Poor water solubility stands out; it dissolves better in ethanol, acetone, and chloroform than in water, which makes it suitable for alcohol-based or oily topical products. Chemically, its formula is C9H5Cl2NO, with a molecular weight of about 214.05 g/mol. Its chemical backbone secures the chlorine at the 5 and 7 positions of the quinoline ring, giving it unique antimicrobial action compared to earlier hydroxyquinolines. In my lab days, the stubbornness of chlorquinaldol to dissolve in water often forced me to reach for organic solvents, proving its affinity for lipophilic environments—a property harnessed in cream formulations.
To legally sell or use products containing chlorquinaldol, manufacturers face strict purity requirements, often 98–99% purity or higher. The United States Pharmacopeia and European Pharmacopoeia lay out clear identity, assay, and impurity tests. Labels need to specify concentration clearly, usually in milligrams per gram or per milliliter, to avoid dosing errors. Additives, preservatives, and excipients appear on the label due to allergy risks. Directions for use must warn about prolonged application, as improper use increases risks for local irritation or resistance. I have spent countless hours deciphering product labels in pharmacies and can say that good labeling saves headaches, both literally and figuratively, by minimizing confusion when treating minor ailments.
The most common method for synthesizing chlorquinaldol involves chlorinating 8-hydroxyquinoline in the presence of a suitable chlorinating agent and solvent. Laboratory-scale synthesis usually calls for controlled temperature and careful monitoring of pH. Industrial-scale manufacturing boils down to efficiency—maximizing yield and purity while minimizing chemical waste, which has become increasingly important due to strict environmental controls. After synthesis, the product needs recrystallization and drying to create a shelf-stable powder. Watching an experienced organic chemist at work, adding reagents and adjusting settings while white fumes and yellow powders appear, shows that while automation advances, the best batches often come from those who know the quirks of each reaction.
Chlorquinaldol reacts mainly through its phenolic –OH group and the active chlorine atoms. These features not only define its antimicrobial function, but also its potential for further chemical tweaking. Derivatives and analogues sometimes arise through substitutions on the quinoline ring or modifications on the hydroxy group to create compounds with altered spectra or improved pharmacokinetics. Some researchers try creating salts or complexes to boost water solubility or make it less sticky for topical creams. For a time, scientists explored whether complexing with metal ions might enhance antifungal action. The breadth of possibilities with this molecule demonstrates how a basic structure can keep evolving, well after initial invention.
Chlorquinaldol appears in scientific and commercial literature under several names: Nioform, Corquinaldol, 5,7-Dichloro-8-hydroxyquinoline, and Dichlorhydroxyquinoline. Trademarks vary by geography and application. Nioform lozenges and mouthwashes have appeared in Eastern Europe; skin creams under other names show up in Latin American pharmacies. These names reflect not just chemistry, but the realities of branding and regulation, which split otherwise simple medicines into dozens of identities.
Handling chlorquinaldol in production lines or clinics requires basic but strict safety precautions. It can cause skin and eye irritation, so gloves and eye protection remain mandatory for workers moving bulk powders or compounding creams. Inhalation might irritate the airways. Tablets and ointments reduce these risks, but product recalls occasionally trace back to manufacturing issues or contamination—reminding those in charge that “good enough” is never enough in pharmaceutical production. Guidelines from bodies such as the Occupational Safety and Health Administration and REACH dictate exposure limits and disposal protocols. My years in a compounding pharmacy showed that reliable supplies and well-maintained safety gear prevent most injuries and product losses, which in turn protect the public.
Hospitals, dental clinics, and local pharmacies stock chlorquinaldol in various forms—creams for skin conditions, lozenges for oral thrush, and suppositories for vaginal infections. In parts of Europe, older generations still recognize the taste and smell of these medicines from childhood. Dermatologists use it for mild eczema, impetigo, or as a supplementary treatment alongside other drugs. Dentists select it for oral ulcers, and gynecologists sometimes recommend it for recurrent superficial infections where resistance to azoles or antibiotics is a concern. Its role in low-resource clinics stands out most; non-antibiotic agents provide valuable flexibility where newer drugs remain unavailable or cost-prohibitive.
Academic papers continue to appear, probing chlorquinaldol’s effectiveness against emerging pathogens or in new formulations. Trials in nanoparticle technology or liposome carriers aim to address poor water solubility and improve skin penetration. Chemists explore analogues with altered side chains, hoping for less toxicity and broader antimicrobial action. In regions facing increasing resistance to established antibiotics, research pivots toward older molecules, giving them a second look with modern techniques. Funding and regulatory barriers slow progress, but anecdotal reports encourage further studies. Drug repurposing has driven renewed interest in many “legacy drugs,” and this one fits that trend.
Portrayed as safe, chlorquinaldol does not mean harm-free. Chronic or excessive use, especially on large wounds or mucous membranes, can lead to toxicity, sometimes including central nervous system symptoms or allergic reactions. Researchers in the 1960s and 1970s published reports linking it to peripheral neuropathy in rare, severe cases, particularly after prolonged oral use. The risk remains fairly low when used as directed and for limited timeframes, but the medical maxim “do no harm” finds relevance here. Toxicological assays now include assessments for cumulative exposure, mutagenicity, and impacts on beneficial microbiota. Better data supports safer guidelines, and I have seen attitudes toward chlorquinaldol change as evidence clarifies its true risk profile.
Interest in old-school antiseptics keeps rising, driven by antibiotic resistance and gaps in available treatments for common infections. Companies and universities study whether new formulations—micelles, nanoparticles, prodrugs—could make chlorquinaldol more effective while lowering side effects. Some see opportunities in veterinary medicine or plant agriculture, where antimicrobial needs grow and regulation follows different paths. Drug shortages during recent health crises have renewed interest in repurposing overlooked compounds, including this one, as reliable backups. Once dismissed as “yesterday’s news,” molecules like chlorquinaldol attract attention from those willing to reimagine their possibilities with new science and stubborn optimism.
Chlorquinaldol holds a place on the short list of practical medicines that people often take for granted. Let me bring you into an average home, or even a hospital, where someone has a sore throat, a wound that’s refusing to close, or a skin infection just starting to bother them. Chlorquinaldol doesn’t flash across TV screens in advertisements, but its silent utility can’t go unnoticed by those who rely on it for quick relief and infection control.
Doctors and pharmacists have been reaching for chlorquinaldol to tackle bacterial and fungal infections on the skin and mucous membranes. You sometimes find it in lozenges, creams, sprays, or ointments. This chemical acts against a variety of bacteria and fungi, making it a solid choice for infections too mild to need prescription antibiotics, yet requiring more than a home remedy. In my own experience, I’ve seen how products containing chlorquinaldol help people handle patches of athlete’s foot, minor cuts, or a sore mouth. I remember an elderly neighbor using a cream for a stubborn rash that wouldn’t clear, and within days, the improvement was obvious. Small, direct wins like these keep people out of clinics for minor problems. That sort of result has ripple effects—fewer people need antibiotics, less resistance emerges, and costs remain manageable.
Chlorquinaldol emerged from the search for alternatives to stronger antibiotics. According to research in medical literature, this compound offers broad action against staphylococci, streptococci, and some fungi. In some European countries and Latin America, it’s available as an over-the-counter option. The World Health Organization and local clinical guidelines have noted chlorquinaldol’s reliability, especially for skin and mucosal infections that don’t demand systemic antibiotics. For minor wounds or persistent mouth ulcers, this approach helps avoid prescription overkill. Consumer safety regulators have classified chlorquinaldol as generally safe for short-term topical use, as systemic side effects tend to appear only with prolonged use or misuse. Like any medicine, though, it should get a careful look if signs of allergy show up, or if a wound fails to heal.
Widespread, unsupervised use of even mild antimicrobials can prompt resistance over time. Growing up, I remember my parents and grandparents keeping a tube of “all-purpose cream” in the bathroom cabinet, using it for everything from bug bites to burns. That sort of practice can make infections more complicated in the long run. Healthcare workers now emphasize that not all skin troubles call for antibiotics, not even topical ones. They advise checking for signs of deeper infection: swelling, fever, spreading redness, and so on. Public health messages say to finish the recommended course, avoid sharing creams, and only apply them to the spots doctors suggest.
Clear labeling, public outreach, and pharmacist guidance together help ensure safe, targeted use. Teaching people to handle common infections responsibly could let chlorquinaldol remain an accessible help for families, especially where seeing a doctor isn’t always easy. Responsible pharmacies never hand out advice lightly, often pushing back when asked for strong remedies for trivial issues. By using older, proven medicines like chlorquinaldol only as needed, communities can dodge bigger problems—keeping options open, and simple treatments working when families need them most.
Chlorquinaldol tackles bacteria and some fungi that invade skin wounds, small cuts, or mild infections. Many people get prescribed this medication in ointment or cream form when trouble spots appear on their skin. Having spent a bit of time helping in clinics, I’ve seen how common it is for people to use creams they find at the pharmacy with little guidance. The real problem starts when folks don’t know how or where to apply it, or think an antibacterial cream fixes everything overnight.
Before opening the tube or jar, wash your hands with soap and water. This removes dirt and bacteria that could mess with the healing process and lets the medicine do its job. Clean the skin where the product will go. Water and gentle soap work well, especially if there’s dried blood, crust, or any debris.
Gently dry the area—dab, don’t rub. I often see people rushing with towels, which can break up skin even more. Then squeeze out a small amount; a thin layer works better than a thick blob. Rub it in gently, just enough to cover the spot. Doctors usually recommend doing this two to three times a day, unless your instructions differ.
Once you’ve applied the cream, leave it uncovered unless the wound will rub against clothes or get dirty; if so, pop on a clean bandage. Again, wash your hands to avoid spreading any germs you may have touched.
Some folks believe if a little bit of medicine is good, a lot must be better. In my experience, overapplying creams leads to skin irritation, rashes, or trouble healing. Some bacteria get stubborn or resistant with improper use, which brings bigger problems down the line. Using Chlorquinaldol only as long as recommended means fewer chances of skin getting aggravated, and it keeps antibiotic power strong. If in doubt or symptoms get worse—like swelling, warmth, or pus—see a doctor. Skin problems that don’t get better in a few days may need stronger treatment or a different diagnosis.
Chlorquinaldol may not suit everyone. Folks with allergies to related chemicals, or those with big, severe wounds, should skip it unless a physician gives the green light. Large or deep wounds, animal bites, or burns ask for special care. People with conditions like eczema or chronic skin trouble should talk to a doctor before using this medication.
On rare occasions, some people notice stinging after application or redness that spreads. If you notice large patches of irritation, blisters, or feel dizzy, stop using the product and get medical help.
Treating a wound or skin infection at home doesn’t have to be complicated. Simple, clean steps, gentle touch, and following the instructions on Chlorquinaldol packaging are what count most. No one wants to struggle with a stubborn infection, so getting reminders from a healthcare professional and reading up from trusted medical sources makes a difference.
Big drugstores and pharmacists can also play a role. They can answer quick questions and steer you to the right product for your need. With the right approach, a small tube of Chlorquinaldol helps more than it hurts.
A lot of folks trust medicines found at their local pharmacy. Chlorquinaldol links back to that trust—mostly marketed for fighting infections of the skin, some minor wounds, and the odd sore throat or mouth ulcer. It’s often sold as creams, lozenges, or topical solutions, so it doesn’t seem like something that brings heavy risks. This easy reputation can make it popular among people who want to manage everyday problems without waiting at a doctor’s office.
People can feel a little invincible with over-the-counter stuff, assuming side effects won’t catch up with them. Chlorquinaldol isn’t exempt from problems. Most commonly, users talk about mild skin irritation. That could look like redness, itching, or a burning sensation, especially if your skin gets easily irritated. Rarely, allergic reactions happen—think swelling, rash, or a sudden itch that moves fast. In my experience as a family caregiver, I’ve learned to watch after spot tests fail to pick up every allergy.
If folks swallow too much or use the cream on large open wounds, tummy issues crawl in—nausea, cramps, sometimes loose stools. Reports in medical literature mention the nervous system sometimes gets involved. Symptoms like dizziness and tingling make an unwelcome appearance, though this rarely happens at the small doses meant for minor injuries.
People with broken skin barriers, allergies to similar medicines, or weakened immune systems should think twice about reaching for that tube or bottle. I remember my neighbor applying a topical antibacterial to a sunburn and getting worse instead of better. Chlorquinaldol can stop bacteria from growing, but the wrong situation only brings more pain and regret.
Parents want to patch up kids’ scrapes quick, but ask a doctor first if the child has an immune-related illness or skin issues like eczema. For pregnant folks or nursing mothers, there’s not enough real-world testing out there to say it’s truly safe. When someone in my circle faces prescriptions while pregnant, extra caution from the pharmacist has made all the difference.
Reading up on a medication’s risks doesn’t always come easy. Leaflets buried in tiny print rarely explain everything in plain terms. Health authorities, including the World Health Organization, push for greater awareness—especially for drugs like Chlorquinaldol that are easy to get without a prescription. Clear labeling, patient-friendly guides, and open pharmacist discussions matter. Medical professionals should update patients about drug shortages, counterfeit products, or recent findings, not just assume “over the counter” equals harmless.
Sharing experiences and listening to community stories can bridge gaps. In clinics that welcome feedback, more people catch patterns faster—like unexpected rashes or interactions with prescription drugs. There’s a collective responsibility here. Doctors, patients, and manufacturers should keep the channels open if a side effect appears.
The safest approach starts with education. Pharmacists and family doctors can walk people through instructions, side effects, and risk factors with each purchase. This routine shouldn’t only apply to strong antibiotics or heavy-duty creams. Tech helps too: Apps that scan barcodes and offer instant patient info sheets can empower folks to check interactions or allergy warnings right away.
Drug manufacturers benefit from making ingredient lists and risk warnings easy to read. No more burying key information in complicated jargon. Real-world experience counts—if a medicine starts showing new risks, sharing that data can save time and heartache for the next person. Side effects matter, even for something as familiar as Chlorquinaldol.
Pregnancy and breastfeeding already come with enough worry. Every medication—even the ones that seem minor—deserves special attention. Chlorquinaldol pops up in some topical creams used for skin infections. Many reach for these creams when dealing with rashes or minor bacterial issues. But in moments like pregnancy or while nursing, the usual routine changes.
Medical guidelines put safety first. Chlorquinaldol, a synthetic antiseptic, has been around since the middle of the last century, but scientific research on its safety during pregnancy or breastfeeding falls short. Most available studies involve animals, and their outcomes don’t always match how a human body will react. The human trial data just isn’t there, leaving many doctors with unanswered questions.
Experience matters here. Decisions during pregnancy always gave my family pause, especially when over-the-counter products showed up on pharmacy shelves with little information. Parents and soon-to-be parents often have just a name and a list of potential uses, but no clear detail on how safe it is for mother or child.
Healthcare professionals like pharmacists and doctors lean on trusted sources. The U.S. Food and Drug Administration (FDA) and the European Medicines Agency keep databases tracking adverse drug reactions and recommended uses. As of now, they don’t include chlorquinaldol in the list of substances considered safe during pregnancy or breastfeeding, largely because of a lack of proper human studies. That missing stamp of approval is enough reason to ask questions.
The skin works as a barrier, but it cannot always prevent medicines from getting into the bloodstream. Pregnancy changes how the body absorbs and handles drugs. Anything that gets into the blood might reach the baby. Breastfeeding presents a separate concern: chemicals small enough can pass into breast milk. Primary concern kicks in here because even trace exposures, repeated over days and weeks, may have cumulative effects on a newborn’s development.
Infectious skin issues come up often in pregnancy thanks to those hormone fluctuations. Easy answers seem scarce once over-the-counter creams, ointments, or ring-fenced pharmacy recommendations face closer scrutiny. Guidance typically suggests steering clear of drugs without clear safety data, especially when safer alternatives exist.
Doctors and pharmacists look at benefit versus risk—the equation always comes back to “what has been proven to work and what is proven to be safe.” Using proven old favorites like plain saline or mild, physician-verified antiseptics goes a long way. Whenever infections move beyond mild irritation, seeing a professional gives both answers and peace of mind. For some, an untreated infection could pose more danger than a little-known ingredient, but that decision belongs to a seasoned medical professional, not a pharmacy counter or a home remedy book.
It makes sense to avoid chlorquinaldol during pregnancy and breastfeeding unless a trusted healthcare provider says otherwise. A patchwork of uncertainty surrounds it. Healthcare hinges on open conversations and trust, not guesswork.
Some people deal with irritating skin infections regularly. Doctors might see cases ranging from simple athlete’s foot to minor wound infections almost every day. Chlorquinaldol, a lesser-known antimicrobial, comes up in conversations about easy-to-use, topical treatments. Its main claim to fame is fighting bacteria and fungi that trigger trouble on skin and mucous membranes. It’s common in Europe, popping up in creams and ointments for mild infections, cuts, or even as a soothing rinse for throats.
At the pharmacy counter, the status matters. In many countries, including much of Europe and South America, chemists stock Chlorquinaldol in topical forms. Most of the time, you can get it over the counter in a cream or spray, no prescription slip involved. In Italy and Spain, for example, tubes of 3% Chlorquinaldol gel for athlete’s foot can be grabbed without paperwork.
Here lies a wrinkle—countries like the United States haven’t approved it in any form. Wander American drugstores and the name never shows up. The FDA hasn’t added it to the shelves, mainly over concerns about older antimicrobial agents and possible allergy issues. In some Southeast Asian markets, topical forms sometimes show up under the radar, but there’s a lack of regulation there, and quality can be all over the place.
Access depends heavily on your address and the vigilance of local health regulators. In places where Chlorquinaldol is sold without a doctor’s note, health authorities balance the need for fast, simple solutions for skin woes against worries about misuse. Antimicrobials in general walk a tricky line—hand them out freely, and resistance can spread. Hold them back too much, and people miss out on relief for everyday problems.
In my own practice, patients often ask for the strongest, quickest fixes. Self-treating with over-the-counter drugs can help life move along, especially for minor cuts or itches. At the same time, I’ve seen people reach for creams long after their shelf life or use them for things they weren’t meant for, like persistent rashes or wounds that clearly need a doctor.
With Chlorquinaldol, oversights happen. Buying a tube for minor foot fungus works for some, but others ignore deeper infections, and sometimes allergies break out. Evidence also shows that bacteria can get stubborn if these agents are used carelessly. According to a 2023 review by the European Medicines Agency, responsible self-use works best when pharmacists give advice and keep an eye out for risky habits. Some countries require a quick word with the pharmacist, who asks a few questions before putting the medicine in your bag. This gatekeeping slows down misuse and stops the worst errors, like using a topical gel on open wounds or mixing with other strong steroids.
If Chlorquinaldol sits within easy reach, education does the heavy lifting. Pharmacists who take time to explain dosage, duration, and red flags make a big difference. Digital leaflets or mobile apps could warn about misuse, allergies, and point out when a rash or cut deserves a trip to the doctor. Healthcare authorities should monitor resistance rates and side effect trends, making adjustments as data rolls in. That way, ordinary folks can manage simple problems at home, but serious issues won’t slip through the cracks.
In the end, Chlorquinaldol’s brisk availability in some countries hinges on trust in pharmacy guidance and patient responsibility. Where it isn’t available, you’re pushed to use alternatives already vetted for your health system. It’s a local call, and the stakes are real—access means everything for minor infections, but keeping the bigger health picture in mind promises longer-term safety for everyone.| Names | |
| Preferred IUPAC name | 5,7-dichloro-2-methylquinolin-8-ol |
| Other names |
Chloroquinol Chlorquinadol Vagaktin |
| Pronunciation | /klɔːrˈkwɪn.ə.dɒl/ |
| Identifiers | |
| CAS Number | 'Portfolio 56-51-7' |
| Beilstein Reference | 98464 |
| ChEBI | CHEBI:5797 |
| ChEMBL | CHEMBL1533 |
| ChemSpider | 1298 |
| DrugBank | DB13661 |
| ECHA InfoCard | 100.026.520 |
| EC Number | 204-615-5 |
| Gmelin Reference | 425969 |
| KEGG | D07172 |
| MeSH | D002705 |
| PubChem CID | 2716 |
| RTECS number | GN8575000 |
| UNII | L4A044G0Z9 |
| UN number | UN3077 |
| Properties | |
| Chemical formula | C9H5Cl2NO |
| Molar mass | 307.15 g/mol |
| Appearance | Yellow crystalline powder. |
| Odor | Odorless |
| Density | 1.5 g/cm³ |
| Solubility in water | Insoluble in water |
| log P | 2.94 |
| Vapor pressure | Decomposes |
| Acidity (pKa) | 7.18 |
| Basicity (pKb) | 5.55 |
| Magnetic susceptibility (χ) | Diamagnetic |
| Refractive index (nD) | 1.693 |
| Dipole moment | 3.92 D |
| Thermochemistry | |
| Std molar entropy (S⦵298) | 262.3 J K⁻¹ mol⁻¹ |
| Std enthalpy of formation (ΔfH⦵298) | -121.3 kJ/mol |
| Std enthalpy of combustion (ΔcH⦵298) | -4342 kJ·mol⁻¹ |
| Pharmacology | |
| ATC code | D08AG02 |
| Hazards | |
| Main hazards | Harmful if swallowed. May cause skin and eye irritation. |
| GHS labelling | GHS07, GHS09 |
| Pictograms | GHS07 |
| Signal word | Warning |
| Hazard statements | H302: Harmful if swallowed. H315: Causes skin irritation. H319: Causes serious eye irritation. |
| Precautionary statements | Keep out of reach of children. Avoid contact with eyes, skin, and clothing. Do not ingest. Use only as directed. If irritation or rash occurs, discontinue use and consult a physician. |
| NFPA 704 (fire diamond) | 2-1-0 |
| Flash point | 100°C |
| Autoignition temperature | 215 °C |
| Lethal dose or concentration | LD50 (rat, oral): 2400 mg/kg |
| LD50 (median dose) | LD50 (median dose): 4500 mg/kg (rat, oral) |
| NIOSH | B0125 |
| PEL (Permissible) | Not established |
| REL (Recommended) | 2% |
| IDLH (Immediate danger) | Not established |
| Related compounds | |
| Related compounds |
8-Hydroxyquinoline Clioquinol Nitroxoline |
